CICIV, a causal inference framework that integrates PC-simple-based causal feature selection with conditional instrumental variable (CIV) representation learning, is proposed that prioritized 40 breast cancer-related candidate genes and identified signals that were not captured by conventional correlation-based analyses.
Abstract
Abstract Motivation Identifying transcriptomic factors with potential causal effects on breast cancer progression is important for understanding disease mechanisms and prioritizing therapeutic targets. However, causal-effect estimation from high-dimensional gene-expression data remains challenging because of the large number of variables and potential unmeasured confounding. Results We propose CICIV, a causal inference framework that integrates PC-simple-based causal feature selection with conditional instrumental variable (CIV) representation learning. PC-simple first reduces the dimensionality of transcriptomic data by identifying candidate parent genes, after which CIV estimates and ranks their absolute causal effects. Applied to TCGA-BRCA, CICIV prioritized 40 breast cancer-related candidate genes and identified signals that were not captured by conventional correlation-based analyses. External validation using the independent METABRIC cohort showed consistent effect directions for 21 of the 40 genes, with four genes overlapping in the Top 10 and nine in the Top 20 rankings. Pathway enrichment and literature-based analyses further supported the biological relevance of the prioritized genes. Availability and Implementation The CICIV benchmarking framework and source code are freely available at https://github.com/Zaiwen/CICIV. The software version and test data used in this study are archived at Zenodo (DOI: 10.5281/zenodo.22143976).
This work proposes a framework for identifying confounders of two non-causally related traits by employing cross-trait pleiotropy analysis to detect genetic loci that affect both traits and multi-trait colocalisation to identify molecular phenotypes mediating these effects.
J. Yarmolinsky, F. Cavallo, F. Koskeridis et al.· medRxiv· 0 citations
This work identified 709 variants mapping to 140 risk regions, that are associated with significant variation between REF and ALT alleles, that may influence breast cancer risk through expression of CCDC88C, which in turn could impact prognosis.
K. Mackie, H. Kemp, A. Gunnell et al.· HGG advances· 0 citations
Overall, GeDiRep provides a structured and interpretable framework for high-dimensional gene expression analysis by selecting reduced yet discriminative and biologically meaningful gene subsets.
Cihan Kuzudisli, B. Qaqish, Burcu Bakir-Gungor et al.· Mathematics· 0 citations
MI-POG can be formalized as an information-theoretic framework for genome-wide identification of prognostic biomarkers by quantifying molecular–clinical dependencies by quantifying molecular–clinical dependencies using mutual information.
An approach comprising locus-specific stratification (LSS) and gene regulatory prioritisation score (GRPS), which uniquely considers multi-signals during fine-mapping and target gene identification, to address issues arising from multi-signals in complex diseases.
Jing Zhang, Qiao-Qiao Liu, Ye Zhu et al.· Nature Communications· 0 citations
Genetically proxied plasma RARRES1 is associated with increased LCINS risk and may contribute to disease susceptibility through immune-related alterations involving NKT-cell phenotypes, providing biologically plausible evidence supporting a role for RARRES1 in LCINS pathogenesis and its potential utility in biomarker d...
Jian-Cong Wu, Qi Zhang, Yan-Ming Lin et al.· Current Medicinal Chemistry· 0 citations
Related blog posts
Microsoft Research Blog· microsoft.comNov 12, 2026
What's new in research at Microsoft? Host Anson Ho explores the latest, including AI-powered universal translation, a breakthrough in a 31-year-old mathematics challenge, and advances making AI coding agents faster and more efficient. The post Microsoft Research Focus – Edition #98 appeared first on Microsoft Research.
AI agents can generate code at a scale that’s hard for humans to review line-by-line. PDD Kit helps ensure the code is doing what the developer intended by creating formal specifications and testing against them. It converts developer intent into a Verus specification, proves AI-generated code meets it for every input, and uses tests where proofs aren't practical. Developers review intent, not every line. The post Formally verifying agent-written full-stack web apps with PDD Kit appeared first o…